Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.

• Westwood S Department of Psychiatry, University of Oxford, UK.
• Baird AL Department of Psychiatry, University of Oxford, UK.
• Anand SN Department of Psychiatry, University of Oxford, UK.
• Nevado-Holgado AJ Department of Psychiatry, University of Oxford, UK.
• Kormilitzin A Department of Psychiatry, University of Oxford, UK.
• Shi L Department of Psychiatry, University of Oxford, UK.
• Hye A Maurice Wohl Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK.
• Ashton NJ Maurice Wohl Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK.
• Morgan AR Dementia Research Institute Cardiff, Cardiff University, Cardiff, UK.
• Bos I Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Centrum Limburg, Maastricht University, Maastricht, the Netherlands.
• Vos SJB Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Centrum Limburg, Maastricht University, Maastricht, the Netherlands.
• Baker S Janssen R&D, Titusville, NJ, USA.
• Buckley NJ Department of Psychiatry, University of Oxford, UK.
• Ten Kate M Alzheimer Center, VU University Medical Center, Amsterdam, the Netherlands.
• Scheltens P Alzheimer Center, VU University Medical Center, Amsterdam, the Netherlands.
• Teunissen CE Alzheimer Center, VU University Medical Center, Amsterdam, the Netherlands.
• Vandenberghe R University Hospital Leuven, Leuven, Belgium.
• Gabel S University Hospital Leuven, Leuven, Belgium.
• Meersmans K University Hospital Leuven, Leuven, Belgium.
• Engelborghs S Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, University of Antwerp, Antwerp, Belgium.
• De Roeck EE Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, University of Antwerp, Antwerp, Belgium.
• Sleegers K Center for Neurosciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
• Frisoni GB University of Geneva, Geneva, Switzerland.
• Blin O AIX Marseille University, INS, Ap-Hm, Marseille, France.
• Richardson JC Neurosciences Therapeutic Area, GlaxoSmithKline R&D, Stevenage, UK.
• Bordet R University of Lille, Inserm, CHU Lille, France.
• Molinuevo JL Alzheimer's Disease & Other Cognitive Disorders Unit, Hopsital Clínic-IDIBAPS, Barcelona, Spain.
• Rami L Barcelona Beta Brain Research Center, Unversitat Pompeu Fabra, Barcelona, Spain.
• Wallin A Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
• Kettunen P Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
• Tsolaki M 1st Department of Neurology, AHEPA University Hospital, Makedonia, Thessaloniki, Greece.
• Verhey F Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Centrum Limburg, Maastricht University, Maastricht, the Netherlands.
• Lléo A Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
• Sala I Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
• Popp J University Hospital of Lausanne, Lausanne, Switzerland.
• Peyratout G University Hospital of Lausanne, Lausanne, Switzerland.
• Martinez-Lage P Geriatric Psychiatry, Department of Mental Health and Psychiatry, Geneva University Hospitals, Geneva, Switzerland.
• Tainta M CITA-Alzheimer Foundation, San Sebastian, Spain.
• Johannsen P Danish Dementia Research Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
• Freund-Levi Y Department of Neurobiology, Caring Sciences and Society (NVS), Division of Clinical Geriatrics, Karolinska Institutet, and Department of Geriatric Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
• Frölich L Department of Geriatric Psychiatry, Zentralinstitut für Seelische Gesundheit, University of Heidelberg, Mannheim, Germany.
• Dobricic V Lübeck Interdisciplinary Platform for Genome Analytics, Institutes of Neurogenetics and Cardiogenetics, University of Lübeck, Lübeck, Germany.
• Legido-Quigley C Kings College London, London, UK.
• Bertram L Lübeck Interdisciplinary Platform for Genome Analytics, Institutes of Neurogenetics and Cardiogenetics, University of Lübeck, Lübeck, Germany.
• Barkhof F Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherland.
• Zetterberg H Department of Psychiatry and Neurochemistry, University of Gothenburg, Mölndal, Sweden.
• Morgan BP Dementia Research Institute Cardiff, Cardiff University, Cardiff, UK.
• Streffer J Center for Neurosciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
• Visser PJ Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Centrum Limburg, Maastricht University, Maastricht, the Netherlands.
• Lovestone S Department of Psychiatry, University of Oxford, UK.

Alzheimer’s disease

amyloid-β

biomarkers

plasma

proteomics